MX2015007091A - Orally administered liquid formulation. - Google Patents
Orally administered liquid formulation.Info
- Publication number
- MX2015007091A MX2015007091A MX2015007091A MX2015007091A MX2015007091A MX 2015007091 A MX2015007091 A MX 2015007091A MX 2015007091 A MX2015007091 A MX 2015007091A MX 2015007091 A MX2015007091 A MX 2015007091A MX 2015007091 A MX2015007091 A MX 2015007091A
- Authority
- MX
- Mexico
- Prior art keywords
- liquid formulation
- orally administered
- mass
- medicine
- vitamin
- Prior art date
Links
- 239000012669 liquid formulation Substances 0.000 title abstract 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 3
- 229930003471 Vitamin B2 Natural products 0.000 abstract 3
- 241000411851 herbal medicine Species 0.000 abstract 3
- 229960002477 riboflavin Drugs 0.000 abstract 3
- 239000011716 vitamin B2 Substances 0.000 abstract 3
- 235000019164 vitamin B2 Nutrition 0.000 abstract 3
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 abstract 2
- 241000894007 species Species 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 229940074391 gallic acid Drugs 0.000 abstract 1
- 235000004515 gallic acid Nutrition 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
An orally administered liquid formulation, characterized by being obtained by blending a) vitamin B2 or an orally administrable sale thereof, b) an herbal-medicine-derived component, c) 1-10 parts by mass of polyvinyl pyrrolidone with respect to 1 part by mass (raw herbal medicine amount) of the herbal-medicine-derived component, and d) 0.02-1.6 parts by mass of at least one species selected from gallic acid and a derivative thereof with respect to 1 part by mass of vitamin B2. This orally administered liquid formulation has the excellent stability of a vitamin B2 species and does not precipitate in a liquid formulation, and can be applied in the fields of medicine and food products.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012266256 | 2012-12-05 | ||
PCT/JP2013/080662 WO2014087818A1 (en) | 2012-12-05 | 2013-11-13 | Orally administered liquid formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015007091A true MX2015007091A (en) | 2015-09-25 |
Family
ID=50883243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015007091A MX2015007091A (en) | 2012-12-05 | 2013-11-13 | Orally administered liquid formulation. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20150343009A1 (en) |
JP (1) | JP6191616B2 (en) |
CN (1) | CN105007923A (en) |
MX (1) | MX2015007091A (en) |
PH (1) | PH12015501152A1 (en) |
SG (1) | SG11201504068UA (en) |
TW (1) | TW201438762A (en) |
WO (1) | WO2014087818A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11083738B2 (en) * | 2017-09-28 | 2021-08-10 | Natals, Inc. | Dietary nutrient compositions |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3460089B2 (en) * | 1991-12-10 | 2003-10-27 | 第一薬品工業株式会社 | Internal liquids that prevent off-flavor generation |
JPH06145056A (en) * | 1992-06-05 | 1994-05-24 | Zeria Pharmaceut Co Ltd | Solution containing vitamin b |
JP3658878B2 (en) * | 1996-08-05 | 2005-06-08 | 大正製薬株式会社 | Oral solution |
JP2001213764A (en) * | 2000-01-31 | 2001-08-07 | Taisho Pharmaceut Co Ltd | Liquid agent for internal use |
JP4168811B2 (en) * | 2003-04-07 | 2008-10-22 | 大正製薬株式会社 | Beverage composition |
JP5040060B2 (en) * | 2004-10-14 | 2012-10-03 | 大正製薬株式会社 | Methionine combination oral solution |
KR101326397B1 (en) * | 2005-12-28 | 2013-11-11 | 라이온 가부시키가이샤 | Liquid medicine for internal use |
JP5125146B2 (en) * | 2006-03-02 | 2013-01-23 | 大正製薬株式会社 | Oral solution |
JP5089956B2 (en) * | 2006-10-13 | 2012-12-05 | ライオン株式会社 | Liquid medicine product for internal use |
TW201340888A (en) * | 2012-03-09 | 2013-10-16 | Takeda Pharmaceutical | Oral solution |
-
2013
- 2013-11-13 SG SG11201504068UA patent/SG11201504068UA/en unknown
- 2013-11-13 CN CN201380063510.7A patent/CN105007923A/en active Pending
- 2013-11-13 WO PCT/JP2013/080662 patent/WO2014087818A1/en active Application Filing
- 2013-11-13 TW TW102141286A patent/TW201438762A/en unknown
- 2013-11-13 US US14/647,881 patent/US20150343009A1/en not_active Abandoned
- 2013-11-13 JP JP2014551015A patent/JP6191616B2/en active Active
- 2013-11-13 MX MX2015007091A patent/MX2015007091A/en unknown
-
2015
- 2015-05-22 PH PH12015501152A patent/PH12015501152A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20150343009A1 (en) | 2015-12-03 |
JPWO2014087818A1 (en) | 2017-01-05 |
WO2014087818A1 (en) | 2014-06-12 |
CN105007923A (en) | 2015-10-28 |
SG11201504068UA (en) | 2015-07-30 |
PH12015501152A1 (en) | 2015-08-17 |
JP6191616B2 (en) | 2017-09-06 |
TW201438762A (en) | 2014-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014097151A3 (en) | Autotaxin inhibitors | |
EP3682875A3 (en) | Methods of treating pediatric metabolic syndrome | |
MY169265A (en) | Obesity animal model and methods for making and using thereof | |
PH12016500814B1 (en) | Heteroaryl butanoic acid derivatives | |
WO2013056048A3 (en) | Nutritional products comprising beta-alanine | |
BR112016020181A8 (en) | choline ester lipoic acid compositions and methods of use. | |
PH12016500766A1 (en) | Age-tailored nutritional compositions with a varying protein content | |
PH12014502071A1 (en) | Beta-hydroxy-beta-methylbutyric acid for imrpoving glucose tolerance | |
PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
IN2015DN02999A (en) | ||
EP4233908A3 (en) | Nutritional compositions and infant formulas to promote myelination in the brain | |
WO2016190566A3 (en) | Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient | |
WO2016076607A3 (en) | Pharmaceutical composition and health functional food, containing a red ginseng concentrate with enriched compound k component, for preventing and treating non-alcoholic fatty liver symptom | |
PH12015501152A1 (en) | Orally administered liquid formulation | |
MX2014006574A (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same. | |
MX2022013541A (en) | Gamma-polyglutamic acid and zinc compositions. | |
MX2014006201A (en) | Imatinib solid dosage forms reconstituted just before use. | |
WO2015022560A8 (en) | Stable pharmaceutical composition containing bisoprolol and ramipril | |
WO2016175589A3 (en) | Pharmaceutical composition for preventing or treating respiratory diseases, containing extract of mixed herbal medicines | |
PH12015500530A1 (en) | Beta-hydroxy-beta-methylbutryic acid-containing compositions and uses thereof | |
NZ706070A (en) | Crystalline phase of (3s.3s’) 4,4’-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine | |
MY175269A (en) | Single high dose of mva induces a protective immune response in neonates and infants | |
WO2014145086A3 (en) | Products and methods using lunasin-enriched soy extract mixtures | |
WO2013127539A3 (en) | Pharmaceutical formulation containing flupirtin | |
Shao et al. | Applications of Green Tea Extract in Bakery Products |